+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data



Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data



Pharmacoepidemiology and Drug Safety 25(7): 836-843



Few studies have evaluated the degree to which prescription drug initiators are correctly identified using claims data. We examine the prevalence and predictors of recent statin possession in statin initiators identified using claims data. Among Medicare Current Beneficiary Survey (MCBS) respondents, we used Medicare Part D claims from 2006 to 2011 to identify statin initiators using a 12-month baseline period of no prior statin claims. Using MCBS interview data, we identified those with self-reported statins obtained during the baseline period. We used log-binomial regression to estimate adjusted prevalence ratios (adjPR) and 95% confidence intervals (CI) for predictors of recent statin possession. Among 766 statin initiators identified in prescription claims, 155 (20%) reported recent statin possession during baseline. Beneficiaries with no Part D claims in the past 30 days (adjPR = 1.49, 95%CI: 1.13, 1.96), those with no inpatient, outpatient or physician visits in the past 30 days (adjPR = 1.50, 95%CI: 1.11, 2.03), those with a brand name statin index claim (adjPR = 1.55, 95%CI: 1.19, 2.02), and those with an index claim in January or February (adjPR = 1.50, 95%CI: 1.00, 2.26) had an increased probability of recent statin possession. In a cohort of statin initiators identified using prescription claims, 20% had evidence of statin possession during the baseline period. Pharmacoepidemiologic new user studies may benefit from including sensitivity analyses within subgroups less likely to include prevalent users to assess the robustness of key findings to misidentification of the time of treatment initiation. Copyright © 2016 John Wiley & Sons, Ltd.

(PDF emailed within 0-6 h: $19.90)

Accession: 058599997

Download citation: RISBibTeXText

PMID: 26991151

DOI: 10.1002/pds.3991


Related references

A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data. Cardiovascular Drugs and Therapy 32(3): 265-272, 2018

Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland. Bmj Open 4(6): E005402, 2014

Predictors of statin use among older adults: A nationwide cross-sectional study. Journal of Clinical Lipidology 2018, 2018

Older statin initiators in Finland - cardiovascular risk profiles and persistence of use. Cardiovascular Drugs and Therapy 28(3): 263-272, 2015

Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists. Journal of the American Heart Association 6(10), 2018

Statin Safety in Chinese: A Population-Based Study of Older Adults. Plos One 11(3): E0150990, 2016

Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey Understanding Statin Use in America and Gaps in Patient Education. Journal of Clinical Lipidology 7(3): 245-246, 2013

Predicting life expectancy for community-dwelling older adults from Medicare claims data. American Journal of Epidemiology 178(6): 974-983, 2013

Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010-2015. Clinical Infectious Diseases 67(3): 378-387, 2018

Patterns of Statin Use in Older Medicare Beneficiaries With Traumatic Brain Injury. Journal of Pharmacy Technology 33(4): 156-166, 2017

Statin therapy and reductions in low-density lipoprotein cholesterol: Initial clinical data on the potent new statin rosuvastatin. American Journal of Cardiology 87(5A): 33B-36B, March 8, 2001

Mortality and Associated Morbidities Following Traumatic Brain Injury in Older Medicare Statin Users. Journal of Head Trauma Rehabilitation 33(6): E68-E76, 2018

Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults: Validation of an Existing Medicare Claims-based Algorithm. Epidemiology 29(4): 556-561, 2018

Impact of statin guidelines on statin utilization and costs in an employer-based primary care clinic. American Journal of Managed Care 23(12): E387-E393, 2018

Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data. Annals of the Rheumatic Diseases 76(10): 1669-1678, 2017